OppenheimerFunds Inc. lowered its holdings in Express Scripts Holding (NASDAQ:ESRX) by 13.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,643,751 shares of the company’s stock after selling 418,511 shares during the quarter. OppenheimerFunds Inc. owned 0.47% of Express Scripts worth $197,329,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in ESRX. SeaCrest Wealth Management LLC acquired a new stake in Express Scripts during the fourth quarter valued at $105,000. Bank of Nova Scotia Trust Co. acquired a new stake in Express Scripts during the third quarter valued at $120,000. Monroe Bank & Trust MI grew its position in Express Scripts by 74.8% during the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after buying an additional 970 shares during the period. Harvest Fund Management Co. Ltd acquired a new stake in Express Scripts during the fourth quarter valued at $183,000. Finally, Atlas Brown Inc. acquired a new stake in Express Scripts during the fourth quarter valued at $212,000. Hedge funds and other institutional investors own 89.08% of the company’s stock.
Express Scripts Holding (NASDAQ ESRX) opened at $76.02 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.67 and a quick ratio of 0.55. The firm has a market cap of $42,840.00, a PE ratio of 9.82, a PEG ratio of 0.94 and a beta of 0.94. Express Scripts Holding has a 52 week low of $55.80 and a 52 week high of $85.07.
Express Scripts declared that its Board of Directors has approved a share repurchase program on Monday, December 18th that permits the company to buyback 45,000,000 outstanding shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are usually a sign that the company’s board of directors believes its shares are undervalued.
In other Express Scripts news, VP Glen D. Stettin sold 3,448 shares of Express Scripts stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total transaction of $262,048.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Everett Neville sold 4,895 shares of Express Scripts stock in a transaction dated Thursday, March 1st. The stock was sold at an average price of $75.26, for a total transaction of $368,397.70. The disclosure for this sale can be found here. Over the last three months, insiders sold 11,792 shares of company stock worth $909,815. Insiders own 0.68% of the company’s stock.
Several research firms recently commented on ESRX. William Blair lowered shares of Express Scripts from an “outperform” rating to a “market perform” rating in a research report on Thursday, March 8th. Sanford C. Bernstein raised shares of Express Scripts from an “underperform” rating to a “market perform” rating in a report on Monday, March 12th. Mizuho set a $96.00 price objective on shares of Express Scripts and gave the company a “hold” rating in a report on Thursday, March 8th. Zacks Investment Research raised shares of Express Scripts from a “hold” rating to a “buy” rating and set a $84.00 price objective on the stock in a report on Tuesday, March 6th. Finally, Barclays assumed coverage on shares of Express Scripts in a report on Thursday, March 8th. They set an “equal weight” rating and a $84.00 price objective on the stock. Three analysts have rated the stock with a sell rating, fourteen have issued a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $81.97.
TRADEMARK VIOLATION NOTICE: This news story was posted by BBNS and is the sole property of of BBNS. If you are viewing this news story on another site, it was copied illegally and reposted in violation of United States & international copyright & trademark legislation. The original version of this news story can be viewed at https://baseballnewssource.com/2018/03/17/oppenheimerfunds-inc-sells-418511-shares-of-express-scripts-holding-esrx/1903771.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.